Global CRO Icon has appointed Dr. Steve Cutler to the Icon board of directors.

Cutler joined Icon in 2011 as group president, Icon Clinical Research Services. Cutler successfully led the business to significant growth and, as a result, was promoted to chief operating officer in January 2014. As chief operating officer, Cutler has responsibility for all of Icon’s operational service areas, including clinical research, early phase, laboratories, DOCS resourcing and commercialization, and outcomes.

Previously, Cutler was chief executive officer of Kendle. Prior to Kendle, Cutler held various senior roles in both Quintiles and Sandoz (now Novartis).

Dublin-based Icon is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries.